Endogenous opiates: 1998

Peptides

Volumn 20, Issue 12, 1999, Pages 1527-1574

  Vaccarino, Anthony L ^a   Olson, Gayle A ^a   Olson, Richard D ^a   Kastin, Abba J ^a,b  

^a UNIVERSITY OF NEW ORLEANS   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activity; Aggression; Alcohol; Cardiovascular responses; Dependence; Depression; Drinking; Eating; Epilepsy; Immunology; Learning Memory; Mental illness; Opiate; Peptide; Respiration; Sex; Stress; Temperature; Tolerance

Indexed keywords

OPIATE; OPIATE RECEPTOR;

AGGRESSION; BEHAVIOR; CARDIOVASCULAR RESPONSE; CORRELATION FUNCTION; DRINKING; EATING; IMMUNITY; LEARNING; MEMORY; NEUROLOGIC DISEASE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RESPIRATION CONTROL; REVIEW; SEX DIFFERENTIATION; STRESS; THERMOREGULATION;

ALCOHOL DRINKING; ANIMALS; BEHAVIOR, ANIMAL; DRINKING; DRUG TOLERANCE; EATING; FEMALE; HUMANS; OPIOID PEPTIDES; PREGNANCY; STRESS; SUBSTANCE-RELATED DISORDERS;

EID: 0033395852     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00166-7     Document Type: Review

References (450)

1. Abysique A., Orsoni P., Bouvier M. Evidence for supraspinal nervous control of external anal sphincter motility in the cat. Brain Res. 795:1998;147-156.
2. Adams M.L., Cicero T.J. Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal. Eur J Pharmacol. 345:1998;1-2.
3. Agmo A., Belzung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology. 37:1998;223-232.
4. Aguilar M.A., Minarro J., Simón V.M. Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol Learn Memory. 69:1998;92-105.
5. Akil H., Owens C., Gutstein H., Taylor L., Curran E., Watson S. Endogenous opioids overview and current issues . Drug Alcohol Depend. 51:1998;127-140.
6. Ally A. Ventrolateral medullary control of cardiovascular activity during muscle contraction. Neurosci Biobehav Rev. 23:1998;65-86.
7. Alvarez C., Prunell M., Boada J. Effect of naloxone on behavioral changes induced by subchronic administration of ethanol in rats. Pharm Biochem Behav. 59:1998;961-965.
8. Amass L., Bickel W.K., Crean J.P., Blake J., Higgins S.T. Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology. 136:1998;217-225.
9. Antelo M.T., Fernández B., Kitchen I., Viveros M.P. Effects of preweanling chronic naltrindole administration on stress-induced antinociceptive responses in rats. Dev Brain Res. 110:1998;127-130.
10. Arcuri E. Can tumors act as opioid traps, mimicking opioid tolerance? J Pain Symptom Manage. 16:1998;78-79.
11. Arends R.H., Hayashi T.G., Luger T.J., Shen D.D. Cotreatment with racemic fenfluramine inhibits the development of tolerance to morphine analgesia in rats. J Pharmacol Exp Ther. 286:1998;585-592.
12. Armstead W.M. Role of opioids in hypoxic pial artery dilation is stimulus duration dependent. Am J Physiol Heart Circ Phys. 44:1998;H861-H867.
13. Armstrong D.W. III. Metabolic and endocrine responses to cold air in women differing in aerobic capacity. Med Sci Sports Exerc. 30:1998;880-884.
14. Asai M., Matamoros-Trejo G., Linares G. Long-term pharmacological kindling increases in vitro release of IR-Met and IR-Leu-enkephalin from amygdala. Comp Biochem Physiol [A]. 120:1998;269-275.
15. Asai M., Zubieta M., Matamoros-Trejo G., Linares G., Agustín P. Diurnal variations of opioid peptides and synenkephalin in vitro release in the amygdala of kindled rats. Neuropeptides. 32:1998;293-299.
16. Asai T. Effects of morphine, nalbuphine and pentazocine on gastric emptying of indigestible solids. Drug Res. 48:1998;802-805.
17. Asai T., Mapleson W.W., Power I. Effects of nalbuphine, pentazocine and U50488H on gastric emptying and gastrointestinal transit in the rat. Br J Anaesth. 80:1998;814-819.
18. Asai T., Power I. Naloxone inhibits gastric emptying in the rat. Anesth Analg. 88:1998;204-208.
19. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. NeuroReport. 9:1998;2265-2267.
20. Asokumar B., Newman L.M., McCarthy R.J., Ivankovich A.D., Tuman K.J. Intrathecal bupivacaine reduces pruritus and prolongs duration of fentanyl analgesia during labor a prospective, randomized controlled trial . Anesth Analg. 87:1998;1309-1315.
21. Babst R., Bongiorno L., Marini M., Marzano M., Spagnoli G., Roda L.G., Urbani A. Age-induced increase of leucine enkephalin enzyme degradation in human plasma. Peptides. 19:1998;1155-1163.
22. Backmund M., Meyer K., Rothenhaeusler H.-B., Soyka M. Opioid detoxification with delta sleep-inducing peptide results of an open clinical trial . J Clin Psychopharmacol. 18:1998;257-258.
23. Bakke M., Hu J.W., Sessle B.J. Morphine application to peripheral tissues modulates nociceptive jaw reflex. NeuroReport. 9:1998;3315-3319.
24. Barr G.A., Zmitrovich A., Hamowy A.S., Liu P.Y.R., Wang S., Hutchings D.E. Neonatal withdrawal after pre- and postnatal exposure to methadone in the rat. Pharm Biochem Behav. 60:1998;97-104.
25. Bauer L.O. Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials. Drug Alcohol Depend. 50:1998;147-155.
26. Bausch S.B., Esteb T.M., Terman G.W., Chavkin C. Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. J Pharmacol Exp Ther. 284:1998;1147-1155.
27. Bedell E.A., DeWitt D.S., Prough D.S. Fentanyl infusion preserves cerebral blood flow during decreased arterial blood pressure after traumatic brain injury in cats. J Neurotrauma. 15:1998;985-992.
28. Beilin Y., Bernstein H.H., Zucker-Pinchoff B., Zahn J., Zenzen W.J. Subhypnotic doses of propofol do not relieve pruritus induced by intrathecal morphine after cesarean section. Anesth Analg. 86:1998;310-313.
29. Belcheva M.M., Bohn L.M., Ho M.T., Johnson F.E., Yanai J., Barron S., Coscia C.J. Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine. Dev Brain Res. 111:1998;35-42.
30. Bell R.L., Soignier R.D., Olson R.D., Vaccarino A.L. Reduction of stress-induced analgesia after ethanol exposure in mice. Life Sci. 63:1998;731-736.
31. Bellchambers C.E., Chieng B., Keay K.A., Christie M.J. Swim-stress but not opioid withdrawal increases expression of c-Fos immunoreactivity in rat periaqueductal gray neurons that project to the rostral ventromedial medulla. Neuroscience. 83:1998;517-524.
32. Bellgowan P.S.F., Helmstetter F.J. The role of μ and κ opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia. Brain Res. 791:1998;83-89.
33. Belzung C., Dubreuil D. Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice. Behav Pharmacol. 9:1998;691-698.
34. Bergant A.M., Kirchler H., Heim K., Daxenbichler G., Herold M., Schröcksnadel H. Childbirth as a biological model for stress? Associations with endocrine and obstetric factors. Gynecol Obstet Invest. 45:1998;181-185.
35. Bergasa N.V., Schmitt J.M., Talbot T.L., Alling D.W., Swain M.G., Turner M.L., Jenkins J.B., Jones E.A. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology. 27:1998;679-684.
36. Bernstein M.A., Welch S.P. μ-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Mol Brain Res. 55:1998;237-242.
37. Bhargava H.N., Cao Y-J. Effect of chronic administration of [D-Pen2, D-Pen5]enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord of mice. Peptides. 19:1998;113-117.
38. Bian J.-S., Zhang W.-M., Xia Q., Wong T-M. Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart. J Mol Cell Cardiol. 30:1998;2103-2110.
39. Biggs T.A., Myers R.D. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats. Pharm Biochem Behav. 60:1998;407-413.
40. Billert H., Fiszer D., Drobnik L., Kurpisz M. Influence of β-endorphin on the production of reactive oxygen and nitrogen intermediates by rabbit alveolar macrophages. Gen Pharmac. 31:1998;393-397.
41. Blalock J.E. β-Endorphin in immune cells. Immunol Today. 19:1998;191-192.
42. Bloom F.E. An overview. Drug Alcohol Depend. 51:1998;215-218.
43. Bond C., LaForge K.S., Tian M., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity possible implications for opiate addiction . Proc Natl Acad Sci. 95:1998;9608-9613.
44. Boundy V.A., Gold S.J., Messer C.J., Chen J., Son J.H., Joh T.H., Nestler E.J. Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. J Neurosci. 18:1998;9989-9995.
45. Boutin H., Jauzac P., MacKenzie E.T., Dauphin F. Maximal densities of μ, δ, and κ receptors are differentially altered by focal cerebral ischemia in the mouse. Brain Res. 787:1998;237-241.
46. Boyle A.E.L., Stewart R.B., Macenski M.J., Spiga R., Johnson B.A., Meisch R.A. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res. 22:1998;359-366.
47. Brady K.T., Dansky B.S., Sonne S.C., Saladin M.E. Post-traumatic stress disorder and cocaine dependence. Order of onset. Am J Addict. 7:1998;128-135.
48. Brandt M.R., France C.P. Chronic I-Alpha acetylmethadol in rhesus monkeys discriminative stimulus and other behavioral measures of dependence and withdrawal . J Pharmacol Exp Ther. 287:1998;1029-1037.
49. Broccardo M., Improta G., Tabacco A. Central effect of SNC 80, a selective and systemically active δ-opioid receptor agonist, on gastrointestinal propulsion in the mouse. Eur J Pharmacol. 342:1998;247-251.
50. Broqua P., Wettstein J.G., Rocher M.-N., Rivière P.J.M., Dahl S.G. The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozine. Eur Neuropsychopharmacol. 8:1998;261-266.
51. Brown C.-H., Ludwig M., Leng G. k-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo. J Neurosci. 18:1998;9480-9488.
52. Brown C.-H., Munro G., Ludwig M., Bull P.M., Leng G., Russell J.A. Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurons in the rat. J Physiol. 507:1998;831-842.
53. Brunton J., Charpak S. μ-opioid peptides inhibit thalamic neurons. J Neurosci. 18:1998;1671-1678.
54. Budai D., Fields H.L. Endogenous opioid peptides acting at μ-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons. J Neurophysiol. 79:1998;677-687.
55. Bunikowski R., Grimmer I., Heiser A., Metze B., Schäfer A., Obladen M. Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr. 157:1998;724-730.
56. Buratti T., Schratzberger P., Dunzendorfer S., Manfreda S.E., Pechlaner C., Joannidis M., Sacerdote P., Panerai A.E., Wiedermann C.J. Decreased levels of β-endorphin in circulating mononuclear leukocytes from patients with acute myocardial infarction. Cardiology. 90:1998;43-47.
57. Burdick K., Yu W.-Z., Ragnauth A., Moroz M., Pan Y.X., Rossi G.C., Pasternak G.W., Bodnar R.J. Antisense mapping of opioid receptor clones effects upon 2-deoxy-D-glucose-induced hyperphagia . Brain Res. 794:1998;359-363.
58. Capasso A., Sorrentino L., Pinto A. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with μ- and κ-opioid receptor agonists. Eur J Pharmacol. 359:1998;127-131.
59. Carr J.A., Carpenter A.M., D'Souza M.M., Elmore A.R., Lovering A.T., Reigel C.E. Alterations in brain and pituitary β-endorphin content in genetically epilepsy-prone rats. Epilepsy Res. 31:1998;113-122.
60. Carr K.D., Park T.H., Zhang Y., Stone E.A. Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad lib fed rats. Brain Res. 779:1998;26-32.
61. Cartwright C.R., Henson L.C., Ward D.S. Effects of alfentanil on the ventilatory response to sustained hypoxia. Anesthesiology. 89:1998;612-619.
62. Caudle R.M., Dubner R. Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus. Neuropeptides. 32:1998;87-95.
63. Cazala P., Norena A., Le Merrer J., Galey D. Differential involvement of the lateral and medial divisions of the septal area on spatial learning processes as revealed by intracranial self-administration of morphine in mice. Behav Brain Res. 97:1998;179-188.
64. Chakrabarti S., Wang L., Tang W.-J., Gintzler A.R. Chronic morphine augments adenylyl cyclase phosphorylation relevance to altered signaling during tolerance/dependence . Mol Pharmacol. 54:1998;949-953.
65. Champion H.C., Bivalacqua T.J., Friedman D.E., Zadina J.E., Kastin A.J., Kadowitz P.J. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat. Peptides. 19:1998;1595-1602.
66. Champion H.C., Bivalacqua T.J., Lambert D.G., McWilliams S.M., Zadina J.E., Kastin A.J., Kadowitz P.J. Endomorphin 1 and 2, the endogenous μ-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat. Life Sci. 63:1998;L131-PL136.
67. Champion H.C., Zadina J.E., Kastin A.J., Kadowitz P.J. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse. Peptides. 19:1998;925-929.
68. Chang J.-Y., Janak P.H., Woodward D.J. Comparison of mesocorticolimbic neuronal responses during cocaine and heroin self-administration in freely moving rats. J Neurosci. 18:1998;3098-3115.
69. Chao C.C., Gekker G., Hu S., Kravitz F., Peterson P.K. κ-Opioid potentiation of TNF-α-induced anti-HIV-1 activity in acutely infected human brain cell cultures. Biochem Pharmacol. 56:1998;397-404.
70. Clapp J.F. III, Kett A., Olariu N., Omoniyi A.T., Wu D., Kim H., Szeto H.H. Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep. Am J Obstet Gynecol. 178:1998;397-401.
71. Code R.A., McDaniel A.E. Development of dynorphin-like immunoreactive auditory nerve terminals in the chick. Dev Brain Res. 106:1998;165-172.
72. Comer S.D., Collins E.D., Wilson S.T., Donovan M.R., Foltin R.W., Fischman M.W. Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol. 345:1998;13-26.
73. Compton P. Pain tolerance in opioid addicts on and off naltrexone pharmacotherapy a pilot study . J Pain Symptom Manage. 16:1998;21-28.
74. Conti F., Pittoni V., Sacerdote P., Priori R., Meroni P.L., Valesini G. Decreased immunoreactive β-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin Exp Rheumatol. 16:1998;729-732.
75. Cook C.D., Picker M.J. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons importance of training dose and attenuation by the D3 agonist ( ± )-7-OH-DPAT . Psychopharmacology. 136:1998;59-69.
76. Coruzzi G., Morini G., Coppelli G., Bertaccini G. The contractile effect of fedotozine on guinea pig isolated intestinal cells is not mediated by kappa opioid receptors. Pharmacology. 56:1998;281-284.
77. Cox E.H., Kerbusch T., Van der Graaf P.H., Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat correlation with the interaction at the μ-opioid receptor . J Pharmacol Exp Ther. 284:1998;1095-1103.
78. Cox E.H., Kuipers J.A., Danhof M. Pharmacokinetic-pharmacodynamic modeling of the EEG effect of alfentanil in rats assessment of rapid functional adaptation . Br J Pharmacol. 124:1998;1534-1540.
79. Craft R.M., Kruzich P.J., Boyer J.S., Harding J.W., Hanesworth J.M. Sex differences in discriminative stimulus and diuretic effects of the κ opioid agonist U69,593 in the rat. Pharm Biochem Behav. 61:1998;395-403.
80. Cramer C.M., Gardell L.R., Boedeker K.L., Harris J.R., Hubbell C.L., Reid L.D. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Pharm Biochem Behav. 60:1998;345-356.
81. Cramer C.M., Hubbell C.L., Reid L.D. A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference. Pharm Biochem Behav. 60:1998;847-853.
82. Crisanti K.C., Fewell J.E. Naloxone does not alter the "regulated" decrease in core temperature during hypoxemia in guinea pigs. J Appl Physiol. 85:1998;1150-1159.
83. Cucchia A.T., Monnat M., Spagnoli J., Ferrero F., Bertschy G. Ultra-rapid opiate detoxification by using deep sedation with oral midazolam short and long-term results . Drug Alcohol Depend. 52:1998;243-250.
84. Cunningham C.L., Henderson C.M., Bormann N.M. Extinction of ethanol-induced conditioned place preference and conditioned place aversion effects of naloxone . Psychopharmacology. 139:1998;62-70.
85. Czapla M.A., Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.J., Kadowitz P.J. Endomorphin 1 and 2, endogenous μ-opioid agonists, decrease systemic arterial pressure in the rat. Life Sci. 62:1998;L175-PL179.
86. D'Amato F.R. Kin interaction enhances morphine analgesia in male mice. Behav Pharmacol. 9:1998;369-373.
87. Dafny N. Is interferon-α a neuromodulator? Brain Res Rev. 26:1998;1-15.
88. Dahan A., Sarton E., Teppema L., Olievier C. Sex-related differences in the influence of morphine on ventilatory control in humans. Anesthesiology. 88:1998;903-913.
89. Danos P., Kasper S., Grünwald F., Klemm E., Krappel C., Broich K., Höflich G., Overbeck B., Biersack H.J., Möller H.J. Pathological regional cerebral blood flow in opiate-dependent patients during withdrawal a HMPAO-spect study . Biol Psychiatry. 37:1998;194-199.
90. Dar M.S. Involvement of κ-opioids in the mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination. Alcohol Clin Exp Res. 22:1998;444-454.
91. Dashe J.S., Jackson G.L., Olscher D.A., Zane E.H., Wendel G.D. Jr. Opioid detoxification in pregnancy. Obstet Gynecol. 92:1998;854-858.
92. Dawson-Basoa M., Gintzler A.R. Gestational and ovarian sex steroid antinociception synergy between spinal κ and δ opioid systems . Brain Res. 794:1998;61-67.
93. De Fonseca F.R., Navarro M. Role of the limbic system in dependence on drugs. Ann Med. 30:1998;397-405.
94. 3 receptor gene is associated with opiate dependence. Mol Psychiatry. 3:1998;333-336.
95. Durand S.E., Liang W., Brauth S.E. Methionine enkephalin immunoreactivity in the brain of the budgerigar (Melopsittacus undulatus) similarities and differences with respect to oscine songbirds . J Comp Neurol. 393:1998;145-168.
96. Duty S., Henry B., Crossman A.R., Brotchie J.M. Topographical organization of opioid peptide precursor gene expression after repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat. Exp Neurol. 150:1998;223-234.
97. Easterling K.W., Holtzman S.G. Comparison of the discriminative and antinociceptive effects of morphine and its glucoronide metabolites after central or systemic administration in the rat. Psychopharmacology. 140:1998;91-97.
98. Egan T.D., Huizinga B., Gupta S.K., Jaarsma R.L., Sperry R.J., Yee J.B., Muir K.T. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology. 89:1998;562-573.
99. Eisenstein T.K., Hilburger M.E. Opioid modulation of immune responses effects on phagocyte and lymphoid cell populations . J Neuroimmunol. 83:1998;36-44.
100. El-Kadi A.O.S., Sharif S.I. The role of dopamine in the expression of morphine withdrawal. Gen Pharmac. 30:1998;499-505.
101. Emanuele M.A., LaPaglia N., Steiner J., Jabamoni K., Hansen M., Kirsteins L., Emanuele N.V. Reversal of ethanol-induced testosterone suppression in peripubertal male rats by opiate blockade. Alcohol Clin Exp Res. 22:1998;1199-1204.
102. Enrico P., Mura M.A., Esposito G., Serra P., Migheli R., De Natale G., Desole M.S., Miele M., Miele E. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Brain Res. 797:1998;94-102.
103. Erdtmann-Vourliotis M., Mayer P., Riechert U., Grecksch G., Höllt V. Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats. Mol Brain Res. 61:1998;51-61.
104. Erdtmann-Vourliotis M., Riechert U., Mayer P., Grecksch G., Höllt V. Pentylenetretrazole (PTZ)-induced c-Fos expression in the hippocampus of kindled rats is suppressed by concomitant treatment with naloxone. Brain Res. 792:1998;299-308.
105. Fang Y., Kelly M.J., Ronnekleiv O.K. Proopiomelanocortin (POMC) mRNA expression distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus . Mol Brain Res. 55:1998;1-8.
106. Fernández B., Antelo M.T., Kitchen I., Viveros M.P. Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to μ and κ agonists in rats. Pharm Biochem Behav. 62:1998;145-149.
107. Fontana F., Bernardi P., Pich E.M., Boschi S., De Iasio R., Spampinato S. Endogenous opioid peptides and mental stress in congestive heart failure patients. Peptides. 19:1998;21-26.
108. 4 receptor agonists and δ-opioid receptor antagonists act synergistically to stimulate colonic propulsion. Am J Physiol Gastrointest Liver Physiol. 38:1998;G979-G983.
109. Franck J., Lindholm S., Raaschou P. Modulation of volitional ethanol intake in the rat by central δ-opioid receptors. Alcohol Clin Exp Res. 22:1998;1185-1189.
110. Frankel P.S., Harlan R.E., Garcia M.M. The 5-HT3 receptor antagonist, MDL 72222, dose-dependently potentiates morphine-induced immediate-early gene expression in the rat caudate putamen. Brain Res. 814:1998;186-193.
111. Franklin K.B.J. Analgesia and abuse potential an accidental association or a common substrate? Pharm Biochem Behav. 59:1998;993-1002.
112. Frette C., Pezet S., Nabout R.A.E., Bertrand J.-P., Pham Q.T., Kauffmann F., Lafuma C. Relationship of serum neutral endopeptidase E.C.3.4.24.11 activity to alcohol consumption. Alcohol Clin Exp Res. 22:1998;1405-1408.
113. Froehlich J.C., Badia-Elder N.E., Zink R.W., McCullough D.E., Portoghese P.S. Contribution of the opioid system to alcohol aversion and alcohol drinking behavior. J Pharmacol Exp Ther. 287:1998;284-292.
114. Fudala P.J., Yu E., Macfadden W., Boardman C., Chiang C.N. Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts. Drug Alcohol Depend. 50:1998;1-8.
115. Gaiardi M., Bartoletti M., Gubellini C. Facilitatory and inhibitory actions of morphine on the discriminative stimulus properties of D-amphetamine. Pharmacol Res. 38:1998;333-337.
116. Gaiardi M., Bartoletti M., Gubellini C., Bacchi A., Babbini M. Modulation of the stimulus effects of morphine by d-amphetamine. Pharm Biochem Behav. 59:1998;249-253.
117. Gamaro G.D., Xavier M.H., Denardin J.D., Pilger J.A., Ely D.R., Ferreira M.B.C., Dalmaz C. The effects of acute and repeated restraint stress on the nociceptive response in rats. Physiol Behav. 63:1998;693-697.
118. Gannon G.A., Rhind S.G., Suzui M., Zamecnik J., Sabiston B.H., Shek P.N., Shephard R.J. β-endorphin and natural killer cell cytolytic activity during prolonged exercise. Is there a connection? Amer J Physiol Regul Integr C. 44:1998;R1725-R1734.
119. García-García L., Harbuz M.S., Manzanares J., Lightman S.L., Fuentes J.A. RU-486 blocks stress-induced enhancement of proenkephalin gene expression in the paraventricular nucleus of rat hypothalamus. Brain Res. 786:1998;215-218.
120. García-García L., Llewellyn-Jones V., Fernandez I.F., Fuentes J.A., Manzanares J. Acute and repeated ECS treatment increases CRF, POMC, and PENK gene expression in selected regions of the rat hypothalamus. NeuroReport. 9:1998;73-77.
121. Gauthier C.A., Gerak L.R., Bagley J.R., Brockunier L.L., France C.P. The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment. Psychopharmacology. 137:1998;67-73.
122. Gavériaux-Ruff C., Matthes H.W.D., Peluso J., Kiefer B.L. Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene. Proc Natl Acad Sci. 95:1998;6326-6330.
123. Gayle D., Ilyin S.E., Flynn M.C., Plata-Salamán C.R. Lipopolysaccharide (LPS)-, and muramyl dipeptide (MDP)-induced anorexia during refeeding after acute fasting characterization of brain cytokine and neuropeptide systems mRNAs . Brain Res. 795:1998;77-86.
124. Gelot A., Francés B., Gicquel S., Zajac J-M. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. Eur J Pharmacol. 358:1998;203-206.
125. Gelot A., Francés B., Roussin A., Latapie J.-P., Zajac J-M. Anti-opioid efficacy of Neuropeptide FF in morphine-tolerant mice. Brain Res. 808:1998;166-173.
126. Georges F., Normand E., Bloch B., Le Moine C. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system an in situ hybridization study . Dev Brain Res. 109:1998;187-199.
127. Gerak L.R., Brandt M.R., France C.P. Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys ventilation and drug discrimination . Psychopharmacology. 137:1998;164-174.
128. Gerra G., Calbiani B., Zaimovic A., Sartori R., Ugolotti G., Ippolito L., Delsignore R., Rustichelli P., Fontanesi B. Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts. Psychiat Res Neuroimag Sect. 83:1998;117-126.
129. Gerra G., Ferri M., Zaimovic A., Giucastro G., Palladino M., Sartori R., Delsignore R., Maestri D., Marzocchi G., Brambilla F. GABAergic function in detoxified heroin addicts relationship to anxiety disorders . Psychiat Res. 77:1998;89-96.
130. Ghosh S., Patel A.H., Cousins M., Grasing K. Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens. Neurochem Res. 23:1998;877-887.
131. Gillman M.A. A common pathway for addictions. S Afr J Sci. 94:1998;178.
132. Gilmore D.P. The involvement of the endogenous opioids in the regulation of reproduction. Biog Amine. 14:1998;331-354.
133. Giraudo S.Q., Billington C.J., Levine A.S. Effects of opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat. Brain Res. 782:1998;18-23.
134. Giraudo S.Q., Kotz C.M., Billington C.J., Levine A.S. Association between the amygdala and nucleus of the solitary tract in μ-opioid induced feeding in the rat. Brain Res. 802:1998;184-188.
135. Gonzales R.A., Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci. 18:1998;10663-10671.
136. Goodman C.B., Heyliger S., Emilien B., Partilla J.S., Yang Y.T., Lee C.-H., Cadet J.L., Rothman R.B. Regulation of μ binding sites after chronic administration of antibodies directed against specific anti-opiate peptides. Peptides. 19:1998;1703-1709.
137. Greenwald M.K., Stitzer M.L. Butorphanol agonist effects and acute physical dependence in opioid abusers comparison with morphine . Drug Alcohol Depend. 53:1998;17-30.
138. Haghparast A., Semnanian S., Fathollahi Y. Morphine tolerance and dependence in the nucleus paragigantocellularis single unit recording study in vivo . Brain Res. 814:1998;71-77.
139. Hall D.M., Suo J.-L., Weber R.J. Opioid mediated effects on the immune system sympathetic nervous system involvement . J Neuroimmunol. 83:1998;29-35.
140. Harrison C., Smart D., Lambert D.G. Stimulatory effects of opioids. Br J Anaesth. 81:1998;20-28.
141. Harrison L.M., Kastin A.J., Zadina J.E. Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes. Peptides. 19:1998;749-753.
142. Harrison L.M., Kastin A.J., Zadina J.E. Opiate tolerance and dependence receptors, G-proteins, and antiopiates . Peptides. 19:1998;1603-1630.
143. Harrison L.M., Kastin A.J., Zadina J.E. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther. 284:1998;611-617.
144. 2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro transient increases and adaptation to sustained exposure . Expt Neurol. 151:1998;70-76.
145. Hauser K.F., Mangoura D. Diversity of the endogenous opioid system in development novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation . Perspect Dev Neurobiol. 5:1998;437-449.
146. Heiny B.-M., Albrecht V., Beuth J. Correlation of immune cell activities and β-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res. 18:1998;583-586.
147. Heitkamp H.-C., Schulz H., Röcker K., Dickhuth H-H. Endurance training in females changes in β-endorphin and ACTH . Int J Sports Med. 19:1998;260-264.
148. Hersh D., Van Kirk J.R., Kranzler H.R. Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology. 139:1998;44-52.
149. Higgs S., Cooper S.J. Evidence for early opioid modulation of licking responses to sucrose and intralipid a microstructural analysis in the rat . Psychopharmacology. 139:1998;342-355.
150. Hikita H., Etsuda H., Takase B., Satomura K., Kurita A., Nakamura H. Extent of ischemic stimulus and plasma β-endorphin levels in silent myocardial ischemia. Am Heart J. 135:1998;813-818.
151. Hiramatsu M., Kameyama T. Roles of κ-opioid receptor agonists in learning and memory impairment in animal models. Meth Find Exp Clin Pharmacol. 20:1998;595-599.
152. Hiramatsu M., Murasawa H., Mori H., Kameyama T. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A(1-13), an endogenous κ-opioid receptor agonist. Br J Pharmacol. 123:1998;920-926.
153. Hiramatsu M., Murasawa H., Nabeshima T., Kameyama T. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats. J Pharmacol Exp Ther. 284:1998;858-867.
154. Holland K.L., Norby L.A., Micevych P.E. Peripubertal ontogeny and estrogen stimulation of cholecystokinin and preproenkephalin mRNA in the rat hypothalamus and limbic system. J Comp Neurol. 392:1998;48-57.
155. Hopkins E., Spinella M., Pavlovic Z.W., Bodnar R.J. Alterations in swim stress-induced analgesia and hypothermia after serotonergic or NMDA antagonists in the rostral ventromedial medulla of rats. Physiol Behav. 64:1998;219-225.
156. Hopwood R.M., Mann P.E., Bridges R.S. Reproductive experience and opioid regulation of luteinizing hormone release in female rats. J Reprod Fertil. 114:1998;259-265.
157. Hoskins D.L., Gordon T.L., Crisp T. The effects of aging on mu and delta opioid receptors in the spinal cord of Fischer-344 rats. Brain Res. 791:1998;299-302.
158. Houghton A.K., Valdez J.G., Westlund K.N. Peripheral morphine administration blocks the development of hyperalgesia and allodynia after bone damage in the rat. Anesthesiology. 89:1998;190-201.
159. Houtsmuller E.J., Walsh S.L., Schuh K.J., Johnson R.E., Stitzer M.L., Bigelow G.E. Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance. J Pharmacol Exp Ther. 285:1998;387-396.
160. Hughes N.R., McKnight A.T., Woodruff G.N., Hill M.P., Crossman A.R., Brotchie J.M. Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism. Mov Disord. 13:1998;228-233.
161. Hung C.-F., Wu M.-H., Tsai C.-H., Chu S.-H., Chi J.-F., Su M-J. Electrophysiological mechanisms for the antiarrhythmic activities of naloxone on cardiac tissues. Life Sci. 63:1998;1205-1219.
162. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J Comp Neurol. 399:1998;139-151.
163. Imaizumi M., Miyazaki S., Fushiki T., Kim K.-M., Onodera K. A trial to detect behavioral changes by swimming stress. Meth Find Exp Clin Pharmacol. 20:1998;587-594.
164. Ingram S.L., Vaughan C.W., Bagley E.E., Connor M., Christie M.J. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci. 18:1998;10269-10276.
165. Ishmael J.E., Franklin P.H., Murray T.F. Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats. Psychopharmacology. 140:1998;206-216.
166. Ismail Z., El-Guebaly N. Nicotine and endogenous opioids toward specific pharmacotherapy . Can J Psychiatry. 43:1998;37-42.
167. Itoh E, Fujimiya M, Inui A. Thioperamide, a histamine H3 receptor antagonist, suppresses NPY-but not Dynorphin A-induced feeding in rats. Reg Pept 1998:75-76:373-6.
168. 2 receptors. Synapse. 30:1998;275-283.
169. Jääskeläinen I.P., Hirvonen J., Kujala T., Alho K., Eriksson C.J.P., Lehtokoshi A., Pekkonen E., Sinclair J.D., Yabe H., Näätänen R., Sillanaukee P. Effects of naltrexone and ethanol on auditory event-related brain potentials. Alcohol. 15:1998;105-111.
170. Jick H., Derby L.E., Vasilakis C., Fife D. The risk of seizures associated with tramadol. Pharmacotherapy. 18:1998;607-611.
171. Jin L., Xin L., Gang P., Bo-Yi Q. Agmatine inhibited tolerance to and dependence on morphine in guinea pig ileum in vitro. Acta Pharmacologica Sinica. 19:1998;564-568.
172. Kai T., Onishi H., Koide S., Katayama M., Yamagami S. Developmental and regional alteration of κ-opioid receptors in seizure-susceptible EL mouse brain. Neurochem Res. 23:1998;163-168.
173. Kameyama T., Ukai M., Shinkai N. Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice. Meth Find Exp Clin Pharmacol. 20:1998;555-560.
174. Kamphuis S., Eriksson F., Kavelaars A., Zijlstra J., Van de Pol M., Kuis W., Heijnen C.J. Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production. J Neuroimmunol. 84:1998;53-60.
175. Kan R.E., Hughes S.C., Rosen M.A., Kessin C., Preston P.G., Lobo E.P. Intravenous remifentanil placental transfer, maternal, and neonatal effects . Anesthesiology. 88:1998;1467-1474.
176. Kanarek R.B., Gerstein A.V., Wildman R.P., Mathes W.F., D'anci K.E. Chronic running-wheel activity decreases sensitivity to morphine-induced analgesia in male and female rats. Pharm Biochem Behav. 61:1998;19-27.
177. 2+ transients and contraction in rat ventricular myocytes. Anesthesiology. 89:1998;1532-1542.
178. Kaplan G.B., Coyle T.S. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur J Pharmacol. 362:1998;1-8.
179. Kaplan G.B., Leite-Morris K.A., Sethi R.K., McClelland E.G. Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Res. 788:1998;104-110.
180. Kapui Z., Mikus E.G., Bence J., Gerber K., Boér K., Korbonits D., Borsodi A., Arányi P. Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione,3,7,-dhihydro-3 methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. Drug Res. 48:1998;1147-1155.
181. Kato S. Suppression of inspiratory fast rhythm, but not bilateral short-term synchronization, by morphine in anesthetized rabbit. Neurosci Lett. 258:1998;89-92.
182. Kato S., Fukuda K., Morikawa H., Shoda T., Mima H., Mori K. Adaptations to chronic agonist exposure of μ-opioid receptor-expressing Chinese hamster ovary cells. Eur J Pharmacol. 345:1998;221-228.
183. Katsura M., Hara A., Higo A., Tarumi C., Hibino Y., Ohkuma S. Continuous treatment with morphine increases diazepam binding inhibitor mRNA in mouse brain. J Neurochem. 71:1998;2638-2641.
184. Kavaliers M., Colwell D.D., Choleris E. Sex differences in opioid and N-methyl-D-aspartate mediated nonopioid biting fly exposure induced analgesia in deer mice. Pain. 77:1998;163-171.
185. B receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats. Life Sci. 62:1998;947-952.
186. Keller E.A., Rey A., Gutiérrez A.C., Cancela L.M. Opiate agonist-induced changes in behavioral sensitivity to clonidine are observed in perinatally malnourished rats exposed to chronic stress. Pharm Biochem Behav. 60:1998;1-5.
187. Kelly M.D.W., Hill R.G., Borsodi A., Toth G., Kitchen I. Weaning-induced development of δ-opioid receptors in rat brain differential effects of guanine nucleotides and sodium upon ligand-receptor recognition . Br J Pharmacol. 125:1998;979-986.
188. Kest B., Beczkowska I., Franklin S.O., Lee C.E., Mogil J.S., Inturrisi C.E. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice. Brain Res. 805:1998;131-137.
189. Kest B., Jenab S., Brodsky M., Sadowski B., Belknap J.K., Mogil J.S., Inturrisi C.E. Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia. Brain Res. 816:1998;381-389.
190. Kest B., Lee C.E., Jenab S., Kao B., Inturrisi C.E. Chronic naltrexone differentially affects supraspinal δ-opioid receptor-mediated antinociception. Eur J Pharmacol. 345:1998;47-53.
191. Kest B., McLemore G.L., Sadowski B., Mogil J.S., Belknap J.K., Inturrisi C.E. Acute morphine dependence in mice selectively-bred for high and low analgesia. Neurosci Lett. 256:1998;120-122.
192. Kett A., Omoniyi A.T., Kim H., Olariu N., Wu D., Szeto H.H., Clapp J.F. III. Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous μ-opioid agonists. Am J Obstet Gynecol. 178:1998;950-955.
193. Khanna N., Khosla R., Kohli J. Opioid receptor mediated anticonvulsant effect of pentazocine. Indian J Med Sci. 52:1998;1-7.
194. Kienbaum P., Thürauf N., Michel M.C., Scherbaum N., Gastpar M., Peters J. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after μ-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology. 88:1998;1154-1161.
195. Kimes AS, Maldonado R, Ambrosio E, Koob GF, London. ED. Cerebral glucose metabolism during opioid withdrawal after methylnaloxonium injection into the locus coeruleus. Brain Res 1998;814:1-12.
196. Kimmel H.L., Holtzman S.G. Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat. Eur J Pharmacol. 343:1998;119-127.
197. Kimmel H.L., Justice J.B. Jr, Holtzman S.G. Dissociation of morphine-induced potentiation of turning and striatal dopamine release by amphetamine in the nigrally lesioned rat. Eur J Pharmacol. 346:1998;203-208.
198. Kinney H.C., Filiano J.J., Assmann S.F., Mandell F., Valdes-Dapena M., Krous H.F., O'Donnell T., Rava L.A., White W.F. Tritiated-naloxone binding to brainstem opioid receptors in the sudden infant death syndrome. J Autonomic Ner Sys. 69:1998;156-163.
199. Klein L.C., Popke E.J., Grunberg N.E. Sex differences in effects of opioid blockade on stress-induced freezing behavior. Pharm Biochem Behav. 61:1998;413-417.
200. Klokker M., Mohr T., Kjaer M., Galbo H., Pedersen B.K. The natural killer cell response to exercise in spinal cord injured individuals. Eur J Appl Physiol. 79:1998;106-109.
201. Knapp P.E., Maderspach K., Hauser K.F. Endogenous opioid system in developing normal and jimpy and oligodendrocytes μ and κ opioid receptors mediate differential mitogenic and growth responses . Glia. 22:1998;189-201.
202. Kolesnikov Y., Jain S., Wilson R., Pasternak G.W. Lack of morphine and enkephalin tolerance in 129/SvEv mice evidence for a NMDA receptor defect . J Pharmacol Exp Ther. 284:1998;455-459.
203. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
204. Kostic T., Andric S., Maric D., Kovacevic R. The effect of acute stress and opioid antagonist on the activity of NADPH-P450 reductase in rat leydig cells. J Steroid Biochem Molec Biol. 66:1998;51-54.
205. Kotz C.M., Briggs J.E., Grace M.K., Levine A.S., Billington C.J. Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. Amer J Physiol Regul Integr C. 44:1998;R471-R477.
206. Kovács G.L., Sarnyai Z., Szabó G. Oxytocin and addiction a review . Psychoneuroendocrinology. 23:1998;945-962.
207. 3H](+)-pentazocine labeled σ sites in mouse spinal cord by chronic morphine treatment. Eur J Pharmacol. 350:1998;47-52.
208. Kowalski J. Augmenting effect of opioids on nitrite production by stimulated murine macrophages. Neuropeptides. 32:1998;287-291.
209. 5]enkephalin fragments. Eur J Pharmacol. 347:1998;95-99.
210. Kowalski J. Immunomodulatory action of class μ-, δ- and κ-opioid receptor agonists in mice. Neuropeptides. 32:1998;301-306.
211. Kowalski W.B., Parsons M.T., Pak S.C., Wilson L. Jr. Morphine inhibits nocturnal oxytocin secretion and uterine contractions in the pregnant baboon. Biol Reprod. 58:1998;971-976.
212. Kõks S., Soosaar A., Võikar V., Volke V., Ustav M., Männistö P.T., Bourin M., Vasar E. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze. Neuropeptides. 32:1998;235-240.
213. Kranzler H.R., Gelernter J., O'Malley S., Hernandez-Avila C.A., Kaufman D. Association of alcohol or other drug dependence with alleles of the μ opioid receptor gene (OPRM1). Alcohol Clin Exp Res. 22:1998;1359-1362.
214. Kranzler H.R., Modesto-Lowe V., Nuwayser E.S. Sustained-release naltrexone for alcoholism treatment a preliminary study . Alcohol Clin Exp Res. 22:1998;1074-1079.
215. Kratzer U., Schmidt W.J. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Neurosci Lett. 252:1998;53-56.
216. Kreek M.J., Koob G.F. Drug dependence stress and dysregulation of brain reward pathways . Drug Alcohol Depend. 51:1998;23-47.
217. Krishnan-Sarin S., Wand G.S., Li X.-W., Portoghese P.S., Froehlich J.C. Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharm Biochem Behav. 59:1998;627-635.
218. Kronenberg M.F., Laimer I., Rifici C., Saltuari L., Bramanti P., Moriggl U., Norer B., Kofler A. Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus. Pain. 75:1998;383-387.
219. Kubota K., Takahashi T., Yanagisawa M., Fujibayashi K., Saito K. A novel method for detecting the analgesic effect of drugs by quantifying body movement after noxious stimulation in neonatal rat. J Pharmacol Toxicol Meth. 40:1998;33-37.
220. Kuhn C.M., Schanberg S.M. Responses to maternal separation mechanisms and mediators . Int J Dev Neurosci. 16:1998;261-270.
221. Kussman B.D., Sethna N.F. Pethidine-associated seizure in a healthy adolescent receiving pethidine for postoperative pain control. Paediatr Anaesth. 8:1998;349-352.
222. Kwok E.H., Dun N.J. Endomorphins decrease heart rate and blood pressure possibly by activating vagal afferents in anesthetized rats. Brain Res. 803:1998;204-207.
223. Lamas X., Negus S.S., Gatch M.B., Mello N.K. Effects of heroin/cocaine combinations in rats trained to discriminate heroin or cocaine from saline. Pharm Biochem Behav. 60:1998;357-364.
224. Larcher A., Laulin J.P., Celerier E., Le Moel M., Simonnet G. Acute tolerance associated with a single opiate administration involvement of N-Methyl-D-Aspartate-dependent pain facilitatory systems . Neuroscience. 84:1998;583-589.
225. Lau S.M., Tang F. The effect of aging on the response of striatal preproenkephalin and preprotachykinin mRNA contents to chronic haloperidol treatment in rats measurement by solution-hybridization RNase protection assay . Neurosci Lett. 246:1998;33-36.
226. Le Guen S., Catheline G., Besson J-M. Development of tolerance to the antinociceptive effect of systemic morphine at the lumbar spinal cord level a c-Fos study in the rat . Brain Res. 813:1998;128-138.
227. Legakis I., Saramantis A., Voros D., Chalevelakis G., Tolis G. Dissociation of ACTH, β-endorphin and cortisol in graded sepsis. Horm Metab Res. 30:1998;570-574.
228. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., Bodnar R.J. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur J Pharmacol. 349:1998;R1-R2.
229. Leventhal L., Silva R.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Morphine-6β-glucuronide-induced hyperphagia characterization of opioid action by selective antagonists and antisense mapping in rats . J Pharmacol Exp Ther. 287:1998;538-544.
230. Li X.-W., Li T.-K., Froehlich J.C. Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference. Brain Res. 794:1998;35-47.
231. Lucas L.R., Angulo J.A., Moal M.L., McEwen B.S., Piazza P.V. Neurochemical characterization of individual vulnerability to addictive drugs in rats. Eur J Neurosci. 10:1998;3153-3163.
232. Ma D., Sapsed-Byrne S.M., Chakrabarti M.K., Whitwam J.G. Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits. Acta Anesthesiol Scand. 42:1998;670-677.
233. MacDonald S., Smith M.E., Bailey C.J. Expression of β-endorphin and its receptors in the spinal cord of obese-diabetic ob/ob mice. Neurosci Lett. 248:1998;85-88.
234. Magura S., Kang S.Y., Rosenblum A., Handelsman L., Foote J. Gender differences in psychiatric comorbidity among cocaine-using opiate addicts. J Addict Dis. 17:1998;49-61.
235. Malin D.H., Lake J.R., Shenoi M., Upchurch T.P., Johnson S.C., Schweinle W.E., Cadle C.D. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat. Psychopharmacology. 140:1998;371-377.
236. Malinovsky J.-M., Normand L.L., Lepage J.-Y., Malinge M., Cozian A., Pinaud M., Buzelin J-M. The urodynamic effects of intravenous opioids and ketoprofen in humans. Anesth Analg. 87:1998;456-461.
237. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res. 783:1998;236-240.
238. Maney D.L., Wingfield J.C. Neuroendocrine suppression of female courtship in a wild passerine corticotropin-releasing factor and endogenous opioids . J Neuroendocrinol. 10:1998;593-599.
239. Manocha A., Sharma K.K., Mediratta P.K. Tramadol, a centrally acting opioid anticonvulsant effect against maximal electroshock seizure in mice . Indian J Med Sci. 42:1998;407-411.
240. Mansi J.A., Rivest S., Drolet G. Effect of immobilization stress on transcriptional activity of inducible immediate-early genes, corticotropin-releasing factor, its type 1 receptor, and enkephalin in the hypothalamus of borderline hypertensive rats. J Neurochem. 70:1998;1556-1566.
241. Marinelli M., Barrot M., Simon H., Oberlander C., Dekeyne A., Le Moal M., Piazza P.V. Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur J Neurosci. 10:1998;3269-3275.
242. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence a self-medication hypothesis . Neuropsychopharmacology. 18:1998;135-174.
243. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides. 19:1998;1783-1789.
244. 3H]DAMGO binding to rat brain sections . Drug Alcohol Depend. 52:1998;135-147.
245. Martin T.J., Smith J.E., Dworkin S.I. Training dose and session time as contextual determinants of heroin self-administration in rats. Pharm Biochem Behav. 60:1998;415-421.
246. Martín-Del-Campo A.F., Cortés-Sortres J., Herrera-Ferrá K., Ulloa-Aguirre A. High-dose naloxone (1.0 mg/kg) psychological and endocrine effects in normal male subjects pretreated with one milligram of dexamethasone . Psychoneuroendocrinology. 23:1998;413-424.
247. Mathieu-Kia A.-M., Besson M-J. Repeated administration of cocaine, nicotine and ethanol effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat . Mole Brain Res. 54:1998;141-151.
248. Matsuzawa S., Suzuki T., Misawa M., Nagase H. Involvement of μ- and δ-opioid receptors in the ethanol-associated place preference in rats exposed to foot-shock stress. Brain Res. 803:1998;169-177.
249. 1 receptors in the limbic forebrain of drug deprived rats. Neuropharmacology. 37:1998;997-1006.
250. McBride W.J., Chernet E., McKinzie D.L., Lumeng L., Li T-K. Quantitative autoradiography of μ-opioid receptors in the CNS of alcohol-naive alcohol-preferring P and -nonpreferring NP rats. Alcohol. 16:1998;317-323.
251. McCubbin J.A., Bruehl S., Wilson J.F., Sherman J.J., Norton J.A., Colclough G. Endogenous opioids inhibit ambulatory blood pressure during naturally occurring stress. Psychosomatic Medicine. 60:1998;227-231.
252. McGreevy P., Nicol C. Physiological and behavioral consequences associated with short-term prevention of crib-biting in horses. Physiol Behav. 65:1998;15-23.
253. 5]-enkephalin levels in the developing rat heart. Mol Brain Res. 60:1998;160-167.
254. McLaughlin P.J., Wu Y. Opioid gene expression in the developing and adult rat heart. Dev Dynam. 211:1998;153-163.
255. McNally G.P., Westbrook F. Effects of systemic, intracerebral, or intrathecal administration of an N-Methyl-D-Aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats. Behav Neurosci. 112:1998;966-978.
256. Medina F., Siddiqui A., Scimonelli T., Fenske C., Wilson C.A., Celis M.E. The inter-relationship between gonadal steroids and POMC peptides, β-endorphin and α-MSH, in the control of sexual behavior in the female rat. Peptides. 19:1998;1309-1316.
257. Meis S., Pape H-C. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ. J Neurosci. 18:1998;8133-8144.
258. Mello N.K., Negus S.S. Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther. 286:1998;812-824.
259. Mello N.K., Negus S.S. The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combination and heroin alone by rhesus monkeys. J Pharmacol Exp Ther. 285:1998;444-456.
260. Metz-Boutigue M.-H., Goumon Y., Lugardon K., Strub J.-M., Aunis D. Antibacterial peptides are present in chromaffin cell secretory granules. Cell Mol Neurobiol. 18:1998;249-266.
261. Meyer W.R., Muoio D., Hackney T.C. Effect of sex steroids on β-endorphin levels at rest and during submaximal treadmill exercise in anovulatory and ovulatory runners. Fertil Steril. 71:1998;1085-1091.
262. Mickley G.A., Cobb B.L. Thermal tolerance reduces hyperthermia-induced disruption of working memory a role for endogenous opiates? Physiol Behav. 63:1998;855-865.
263. Miki T., Cohen M.V., Downey J.M. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 186:1998;3-12.
264. Milanes M.V., Laorden M.L., Chapleur-Chateau M., Burlet A. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal correlation with hypothalamic noradrenergic activity and pituitary-adrenal response . J Pharmacol Exp Ther. 285:1998;700-706.
265. Mino A., Page D., Dumont P., Broers B. Treatment failure and methadone dose in a public methadone maintenance treatment program in Geneva. Drug Alcohol Depend. 50:1998;233-239.
266. Miranda H.F., Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharm Biochem Behav. 61:1998;357-360.
267. Mitchell I.J., Cooper A.J., Griffiths M.R., Barber D.J. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons a neural substrate for psychosis . Neuroscience. 84:1998;489-501.
268. Mitrovic I., Napier T.C. Substance P attenuates and DAMGO potentiates amygdala glutamatergic neurotransmission within the ventral pallidum. Brain Res. 792:1998;193-206.
269. Morgan D., Picker M.J. The μ opioid reversible antagonist β-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the μ opioid receptor. Psychopharmacology. 140:1998;20-28.
270. Morgan M.M., Whitney P.K., Gold M.S. Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray. Brain Res. 804:1998;159-166.
271. Mosconi G., Gallinelli A., Polzonetti-Magni A.M., Facchinetti F. Acetyl salmon endorphin-like and interrenal stress response in male gilthead sea bream, Sparus aurata. Neuroendocrinology. 68:1998;129-134.
272. Munro G., Pumford K.M., Russell J.A. Altered cholecystokinin binding site density in the supraoptic nucleus of morphine-tolerant and -dependent rats. Brain Res. 780:1998;190-198.
273. Nantwi K.D., Hicks S., Bradley D. Jr, Schoener E.P. Interactions of buprenorphine and selective dopamine receptor antagonists in the rat nucleus accumbens. Gen Pharmac. 31:1998;425-429.
274. Napier L.D., Stanfill A., Yoshishige D.A., Jackson K.E., Barron B.A., Caffrey J.L. Autonomic control of heart rate in dogs treated chronically with morphine. Am J Physiol Heart Circ Phy. 44:1998;H2199-H2210.
275. 1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. NeuroReport. 9:1998;3397-3402.
276. Negus S.S., Gatch M.B., Mello N.K. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology. 18:1998;325-338.
277. Negus S.S., Gatch M.B., Mello N.K., Zhang X., Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther. 286:1998;362-375.
278. Nelson E.E., Panksepp J. Brain substrates of infant-mother attachment contributions of opioids, oxytocin, and norepinephrine . Neurosci Biobehav Rev. 22:1998;437-452.
279. Ness T.J., Follett K.A. The development of tolerance to intrathecal morphine in rat models of visceral and cutaneous pain. Neurosci Lett. 248:1998;33-36.
280. Effective medical treatment of opiate addiction. JAMA. 280:1998;1936-1943.
281. Nunes E.V., Quitkin F.M., Donovan S.J., Deliyannides D., Ocepek-Welikson K., Woody G. Imipramine treatment of opiate-dependent patients with depressive disorders - A placebo-controlled trial. Arch Gen Psychiatry. 55:1998;153-160.
282. Nunes E.V., Weissman M.M., Goldstein R.B., McAvay G., Seracini A.M., Verdeli H., Wickramaratne P.J. Psychopathology in children of parents with opiate dependence and/or major depression. J Am Acad Child Adolesc Psychiat. 37:1998;1142-1151.
283. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug abuse can they explain compulsion? J Psychopharmacol. 12:1998;15-22.
284. O'Connor P.G., Kosten T.R. Rapid and ultrarapid opioid detoxification techniques. JAMA. 279:1998;229-234.
285. Olmstead M.C., Munn E.M., Franklin K.B.J., Wise R.A. Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci. 18:1998;5035-5044.
286. Olster D.H. Site-specific opioid receptor blockade allows prepubertal guinea pigs to display progesterone-facilitated lordosis. Horm Behav. 33:1998;115-124.
287. Omoniyi A.T., Wu D., Soong Y., Szeto H.H. Baroreflex-mediated bradycardia is blunted by intravenous μ- but not κ-opioid agonists. J Cardiovasc Pharmacol. 31:1998;954-959.
288. Opanashuk L.A., Hauser K.F. Opposing actions of the EGF family and opioids heparin binding-epidermal growth factor (HB-EGF) protects mouse cerebellar neuroblasts against the antiproliferative effect of morphine . Brain Res. 804:1998;87-94.
289. Ottaviani E., Franceschi C. A new theory on the common evolutionary origin of natural immunity, inflammation and stress response the invertebrate phagocytic immunocyte as an eye-witness . Domest Anim Endocrinol. 15:1998;291-296.
290. Ozaita A., Escribá P.V., Ventayol P., Murga C., Mayor F. Jr, García-Sevilla J.A. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J Neurochem. 70:1998;1249-1257.
291. Pabello N.G., Hubbell C.L., Cavallaro C.A., Barringer T.M., Mendez J.J., Reid L.D. Responding for rewarding brain stimulation cocaine and isradipine plus naltrexone . Pharm Biochem Behav. 61:1998;181-192.
292. Pan Z.Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol Sci. 19:1998;94-98.
293. Panagis G., Kastellakis A., Spyraki C. Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum. Psychopharmacology. 139:1998;222-229.
294. Park T.H., Carr K.D. Neuroanatomical patterns of Fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline- and naltrexone-treated rats. Brain Res. 805:1998;169-180.
295. Parker L.A., Joshi A. Naloxone-precipitated morphine withdrawal induced place aversions effect of naloxone at 24 h postmorphine . Pharm Biochem Behav. 61:1998;331-333.
296. Passannte A.N., Hazucha M.J., Bromberg P.A., Seal E., Folinsbee L., Koch G. Nociceptive mechanisms modulate ozone-induced human lung function decrements. J Appl Physiol. 85:1998;1863-1870.
297. Percheron C., Colette C., Mariano-Goulart D., Avignon A., Capeyron O., Boniface H., Bressot N., Monnier L. Relationship between insulin sensitivity, obesity, body fat distribution and β-endophinaemia in obese women. Int J Obesity. 22:1998;143-148.
298. Petrakis I., Carroll K.M., Nich C., Gordon L., Kosten T., Rounsaville B. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug Alcohol Depend. 50:1998;221-226.
299. Petrov E.S., Varlinskaya E.I., Becker L.A., Smotherman W.P. Endogenous mu opioid systems and suckling in the neonatal rat. Physiol Behav. 65:1998;591-599.
300. Petrov E.S., Varlinskaya E.I., Smotherman W.P. Endogenous opioids and the first suckling episode in the rat. Dev Psychobiol. 33:1998;175-183.
301. Pérez-Paredes M., Picó-Aracil F., Fuentes-Jiménez T., Sánchez-Vilanueva J.G., Expósito-Ordonez E., Gonzálvez-Ortega M., González-Caballero E., Nicolás-Garcia F., Nuño de la Rosa J.A., Ruiz-Ros J.A., Ruipérez-Abizanda J.A. Role of endogenous opioids in syncope induced by head-up tilt test and its relationship with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope. Int J Cardiol. 67:1998;211-218.
302. Picker M.J., Cook C.D. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline. Behav Pharmacol. 9:1998;319-328.
303. Pickworth W.B., Fant R.V. Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrinology. 23:1998;131-141.
304. Pignatti C., Stanic' I., Stefanelli C., Tantini B., Rossoni C., Flamigni F. Modulation of the induction of ornithine decarboxylase by some opioid receptor agonists in immune cells and cardiomyocytes. Mol Cell Biochem. 185:1998;47-53.
305. Pineda J., Torrecilla M., Martín-Ruiz R., Ugedo L. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats. Neuropharmacology. 37:1998;759-767.
306. Pita G. Disturbances in recent memory and behavioral changes caused by the treatment with intraventricular morphine administration (IVM) in severe cancer pain. Hum Psychopharmacol Clin Exp. 13:1998;315-323.
307. Plotkin S.R., Banks W.A., Kastin A.J. Enkephalin, PPE mRNA, and PTS-1 in alcohol withdrawal seizure-prone and -resistant mice. Alcohol. 15:1998;25-31.
308. Pomerleau O.F. Endogenous opioids and smoking a review of progress and problems . Psychoneuroendocrinology. 23:1998;115-130.
309. Popik P., Mamczarz J., Fraczek M., Widla M., Hesselink M., Danysz W. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology. 37:1998;1033-1042.
310. Popp R.L., Erickson C.K. The effect of an acute ethanol exposure on the rat brain POMC opiopeptide system. Alcohol. 16:1998;139-148.
311. Pourmotabbed A., Motamedi F., Fathollahi Y., Mansouri F.A., Semnanian S. Involvement of NMDA receptors and voltage-dependent calcium channels on augmentation of long-term potentiation in hippocampal CA1 area of morphine dependent rats. Brain Res. 804:1998;125-134.
312. Prato F.S., Kavaliers M., Thomas A.W., Ossenkopp K-P. Modulatory actions of light on the behavioral responses to magnetic fields by land snails probably occur at the magnetic field detection stage. Proc R Soc Lond. 265:1998;367-373.
313. Preston K.L., Bigelow G.E. Opioid discrimination in humans discriminative and subjective effects of progressively lower training dose . Behav Pharmacol. 9:1998;533-543.
314. Przewlocka B., Lason W., Turchan J., De Bruin N., Van Luijtelaar G. Anatomical and functional aspects of μ opioid receptors in epileptic WAG/Rij rats. Epilepsy Res. 29:1998;167-173.
315. Puig M.M., Pol O. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice. J Pharmacol Exp Ther. 287:1998;1068-1075.
316. Rabadán J.V., Milanés M.V., Laorden M.L. Changes in right atrial catecholamine content in näive rats and after naloxone-induced withdrawal. Br J Anaesth. 80:1998;354-359.
317. Rahman W., Dashwood M.R., Fitzgerald M., Aynsley-Green A., Dickenson A.H. Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia. Dev Brain Res. 108:1998;239-254.
318. Rasmussen D.D., Bryant C.A., Boldt B.M., Colasurdo E.A., Levin N., Wilkinson C.W. Acute alcohol effects on opiomelanocortinergic regulation. Alcohol Clin Exp Res. 22:1998;789-801.
319. Reiner A., Perera M., Paullus R., Medina L. Immunohistochemical localization of DARPP32 in striatal projection interneurons in pigeons. J Chem Neuroanatomy. 16:1998;17-33.
320. Rénéric J.-P., Bouvard M.P. Opioid receptor antagonists in psychiatry. CNS Drugs. 10:1998;365-382.
321. Rho R., Glick S.D. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats. NeuroReport. 9:1998;1283-1285.
322. Rhode D.S., Basbaum A.I. Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat. J Neurosci. 18:1998;4393-4402.
323. 3 receptor modulation of experimental anxiety in mice. Neurosci Lett. 258:1998;155-158.
324. Ridd M.J., Fosbraey P., Kitchen I. The effect of acute kainic acid treatment on mu-opioid receptors in rat brain. Brain Res. 814:1998;26-33.
325. Rivera M., Gintzler A.R. Differential effects of chronic morphine on mRNA encoding adenylyl cyclase isoforms relevance to physiological sequella of tolerance/dependence . Mol Brain Res. 54:1998;165-169.
326. Roizen M.F. How does μ-opioid receptor blockade work in addicted patients? Anesthesiology. 88:1998;1142-1143.
327. Rojavin M.A., Cowan A., Radzievsky A.A., Ziskin M.C. Antipruritic effect of millimeter waves in mice evidence for opioid involvement . Life Sci. 63:1998;L251-PL257.
328. Rosen M.I., Pearsall H.R., Kosten T.R. The effect of lomotrigine on naloxone-precipitated opiate withdrawal. Drug Alcohol Depend. 52:1998;173-176.
329. Rosse R.B., Johri S., Goel M., Rahman F., Jawor K.A., Deutsch S.I. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the weak opiate withdrawal scale. Clin Neuropharmacol. 21:1998;312-315.
330. Rossmanith W.G., Monn M., Benz R. Effects of chronic opioid antagonism on gonadotrophin and ovarian sex steroid secretion during the luteal phase. Clin Endocrinol (Oxf). 49:1998;343-351.
331. Rowlett J.K., Spealman R.D. Opioid enhancement of the discriminative stimulus effects of cocaine evidence for involvement of μ and δ opioid receptors . Psychopharmacology. 140:1998;217-224.
332. Sallerin-Caute B., Lazorthes Y., Deguine O., Francés B., Verdié J.-C., Charlet J.-P., Bastide R. Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance? Neurosurgery. 42:1998;44-50.
333. Salloum I.M., Cornelius J.R., Thase M.E., Daley D.C., Kirisci L., Spotts C. Naltrexone utility in depressed alcoholics. Psychopharmacol Bull. 34:1998;111-115.
334. Sams-Dodd F. Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behavior and social isolation in the rat social interaction test. Neurosci Biobehav Rev. 23:1998;287-293.
335. Sandin J., Nylander I., Georgieva J., Schött P.A., Ögren S.O., Terenius L. Hippocampal dynorphin B injections impair spatial learning in rats a κ-opioid receptor-mediated effect . Neuroscience. 85:1998;375-382.
336. Sayin Ü., Atasoy S., Uzbay I.T., Aricioglu-Kartal F., Koyuncuoglu H. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats. Pharmacol Res. 38:1998;45-51.
337. Schecter M.D., Calcagnetti D.J. Continued trends in the conditioned place preference literature form 1992 to 1996, inclusive, with a cross-indexed bibliography. Neurosci Biobehav Rev. 22:1998;827-846.
338. Scherbaum N., Klein S., Kaube H., Kienbaum P., Peters J., Gastpar M. Alternative strategies of opiate detoxification Evaluation of the so-called ultra-rapid detoxification . Pharmacopsychiatry. 31:1998;205-209.
339. Schildein S., Ågmo A., Huston J.P., Schwarting R.K.W. Intraaccumbens injections of substance P, morphine and amphetamine effects on conditioned place preference and behavioral activity . Brain Res. 790:1998;185-194.
340. Schlaepfer T.E., Strain E.C., Greenberg B.D., Preston K.L., Lancaster E., Bigelow G.E., Barta P.E., Pearlson G.D. Site of opioid action in the human brain
341. Schlenker E.H. Aspartic acid in the arcuate nucleus attenuates the depressive effects of naloxone on ventilation. Resp Physiol. 114:1998;99-107.
342. Schneider G.M., Lysle D.T. Role of central μ-opioid receptors in the modulation of nitric oxide production by splenocytes. J Neuroimmunol. 89:1998;150-159.
343. Schottenfeld R.S., Pakes J.R., Krosten T.R. Prognostic factors in buprenorphine- versus methadone-maintained patients. J Nerv Ment Dis. 186:1998;35-43.
344. Schroeder H., Becker A., Grecksch G., Schroeder U., Hoellt V. The effect of pentylenetetrazol kindling on synaptic mechanisms of interacting glutamatergic and opioid system in the hippocampus of rats. Brain Res. 811:1998;40-46.
345. Schulteis G., Stinus L., Risbrough V., Koob G.F. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats. Neuropsychopharmacology. 19:1998;406-416.
346. Schulteis G., Yackey M., Risbrough V., Koob G.F. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharm Biochem Behav. 60:1998;727-731.
347. Schultz J.E.J., Hsu A.K., Gross G.J. Ischemic preconditioning in the intact rat heart is mediated by δ1-, but not μ- or κ-opioid receptors. Circulation. 97:1998;1282-1289.
348. ATP channels. Amer J Physiol Heart Circ Phy. 43:1998;H909-H914.
349. Schulz S., Höllt V. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur J Neurosci. 10:1998;1196-1201.
350. Seaman R.L., Belt M.I., Doyle J.M., Mathur S.P. Ultra-wideband electromagnetic pulses and morphine-induced changes in nociception and activity in mice. Physiol Behav. 65:1998;263-270.
351. Sepulveda M.J., Hernandez L., Rada P., Tucci S., Contreras E. Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats an in vivo microdialysis study . Pharm Biochem Behav. 60:1998;255-262.
352. Sernyak M.J., Glazer W.M., Heninger G.R., Charney D.S., Woods S.W., Petrakis I.L., Krystal J.H., Price L.H. Naltrexone augmentation of neuroleptics in schizophrenia. J Clin Psychopharmacol. 18:1998;248-251.
353. Severson K., Tackett R.L. Enhanced hemodynamic response to [D-ala(2),D-Met(5)]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement. Life Sci. 62:1998;2219-2229.
354. Sezen S.F., Kenigs V.A., Kapusta D.R. Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats. J Pharmacol Exp Ther. 287:1998;238-245.
355. Shavit Y., Cohen E., Gagin R., Avitsur R., Pollak Y., Chaikin G., Wolf G., Yirmiya R. Effects of prenatal morphine exposure on NK cytotoxicity and responsiveness to LPS in rats. Pharm Biochem Behav. 59:1998;835-841.
356. Sher L. The role of the endogenous opioid system in the effects of acupuncture on mood, behavior, learning, and memory. Med Hypoth. 50:1998;475-478.
357. Shieh K-R. Ontogeny of the diurnal rhythm of tuberoinfundibular dopaminergic neuronal activity in peripubertal female rats possible involvement of cholinergic and opioidergic systems . Neuroendocrinology. 68:1998;395-402.
358. Shippenberg T., Elmer G.I. The neurobiology of opiate reinforcement. Crit Rev Neurobiol. 12:1998;267-303.
359. Silverstein J.H., Beaseley J., Mizuno T.M., London E., Mobbs C.V. Adrenal neuropeptide Y mRNA but not preproenkephalin mRNA induction by stress is impaired by aging in Fischer 344 rats. Mech Ageing Dev. 101:1998;233-243.
360. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B.P., Maldonado R., Kieffer B.L. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17:1998;886-897.
361. Simpson C.W., Resch G.E., Millington W.R., Myers R.D. Glycyl-L-glutamine injected centrally suppresses alcohol drinking in P rats. Alcohol. 16:1998;101-107.
362. Sinclair J.D. New treatment options for substance abuse from a public health viewpoint. Ann Med. 30:1998;406-411.
363. 3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. 15:1998;227-232.
364. Smith M.A., Picker M.J. Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats influence of maintenance dose and relative efficacy at the mu receptor . Psychopharmacology. 140:1998;57-68.
365. Sophronov A., Zvartau E., Kuzmin A. Nifedipine but not verapamil inhibits subjective effects of IV morphine in opiate-dependent patients. Addiction Biol. 3:1998;345-351.
366. Sørensen A.N., Claësson M.H. Effect of the opioid methionine enkephalinamide on signal transduction in human T-lymphocytes. Life Sci. 62:1998;1251-1259.
367. Spanagel R., Kirschke C., Tretter F., Holsboer F. Forced opiate withdrawal under anesthesia augments and prolongs the occurrence of withdrawal signs in rats. Drug Alcohol Depend. 52:1998;251-256.
368. Spanagel R., Sillaber I., Zieglgänsberger W., Corrigall W.A., Stewart J., Shaham Y. Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology. 139:1998;391-401.
369. Specker S., Wananukul W., Hatsukami D., Nolin K., Hooke L., Kreek M.J., Pentel P.R. Effects of dynorphin A(1-13) on opiate withdrawal in humans. Psychopharmacology. 137:1998;326-332.
370. Spector S., Munjal I., Schmidt D.E. Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids in rat brain. Neuropsychopharmacology. 19:1998;417-427.
371. Stefano G.B., Salzet M., Fricchione G.L. Enkelytin and opioid peptide association in invertebrates and vertebrates immune activation and pain . Immunol Today. 19:1998;265-268.
372. Stefano G.B., Salzet M., Rialas C.M., Mattocks D., Fimiani C., Bilfinger T.V. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide endothelial implications . Int J Cardiol. 64:1998;S3-S13.
373. Steine-Martin A., Zhou R., Hauser K.F. Regional, developmental, and cell cycle-dependent differences in μ, δ, and κ-opioid receptor expression among cultured mouse astrocytes. Glia. 22:1998;249-259.
374. Steiner H., Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res. 123:1998;60-76.
375. Stinus L., Robert C., Karasinski P., Limoge A. Continuous quantitative monitoring of spontaneous opiate withdrawal locomotor activity and sleep disorders . Pharm Biochem Behav. 59:1998;83-89.
376. Straub R.H., Dorner M., Riedel J., Kubitza M., Van Rooijen N., Lang B., Schölmerich J., Falk W. Tonic neuorgenic inhibition of IL-6 secretion from murine spleen caused by opioidergic transmission. Amer J Physiol Regul Integr C. 43:1998;R997-R1003.
377. Stromberg M.F., Casale M., Volpicelli L., Volpicelli J.R., O'Brien C.P. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and β-funaltrexamine on ethanol consumption in the rat. Alcohol. 15:1998;281-289.
378. Stromberg M.F., Volpicelli J.R., O'Brien C.P. Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption by using a limited access procedure in the rat. Alcohol Clin Exp Res. 22:1998;2186-2191.
379. Su X., Wachtel R.E., Gebhart G.F. Inhibition of calcium currents in rat colon sensory neurons by K- but not μ- or δ-opioids. J Neurophysiol. 80:1998;3112-3119.
380. Taber M.T., Zernig G., Fibiger H.C. Opioid receptor modulation of feeding-evoked dopamine release in the rat nucleus accumbens. Brain Res. 785:1998;24-30.
381. Takahashi M., Tokuyama S. Pharmacological and physiological effects of ginseng on actions induced by opioids and psychostimulants. Meth Find Exp Clin Pharmacol. 20:1998;77-84.
382. 2-opioid receptors in electrically stimulated longitudinal muscle of guinea pig ileum. Gen Pharmac. 31:1998;215-220.
383. Takeda M., Tanimoto T., Ojima K., Matsumoto S. Suppressive effect of vagal afferents on the activity of the trigeminal spinal neurons related to the jaw-opening reflex in rats Involvement of the endogenous opioid system . Brain Res Bull. 47:1998;49-56.
384. Takita K., Herlenius E., Lindahl S.G.E., Yamamoto Y. Age- and temperature-dependent effects of opioids on medulla oblongata respiratory activity an in vitro study in newborn rat . Brain Res. 800:1998;308-311.
385. 1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and nonpsychostimulant drugs of abuse. Eur J Neurosci. 10:1998;1179-1187.
386. 1 receptor, on rat colonic contraction and transit. Eur J Pharmacol. 353:1998;265-271.
387. Tanimoto M., Fukuoka T., Miki K., Tokunaga A., Tashiro C., Noguchi K. Effects of halothane, ketamine and nitrous oxide on dynorphin mRNA expression in dorsal horn neurons after peripheral tissue injury. Brain Res. 811:1998;88-95.
388. Taylor J.R., Punch L.J., Elsworth J.D. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharmacology. 138:1998;133-142.
389. Tejedo-Real P., Mico J.A., Smadja C., Maldonado R., Roques B.P., Gilbert-Rahola J. Involvement of δ-opioid receptors in the effects induced by endogenous enkephalines on learned helplessness model. Eur J Pharmacol. 354:1998;1-7.
390. Tejwani G.A., Sheu M.-J., Sribanditmongkol P., Satyapriya A. Inhibition of morphine tolerance and dependence by diazepam and its relation to μ-opioid receptors in the rat brain and spinal cord. Brain Res. 797:1998;305-312.
391. Terra S.G., Tsunoda S.M. Opioid antagonists in the treatment of pruritus from cholestatic liver disease. Ann Pharmacother. 32:1998;1228-1230.
392. Thornton S.R., Smith F.L. Long-term alterations in opiate antinociception resulting from infant fentanyl tolerance and dependence. Eur J Pharmacol. 363:1998;113-119.
393. Tokuyama S., Inoue M., Fuchigami T., Ueda H. Lack of tolerance in peripheral opioid analgesia in mice. Life Sci. 62:1998;1677-1681.
394. Tokuyama S., Zhu H., Wakabayashi H., Feng Y.Z., Ho I.K. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. J Biomed Sci. 5:1998;45-53.
395. Torrens M., Castillo C., San L., Del Moral E., González M.L., De La Torre R. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug Alcohol Depend. 52:1998;193-200.
396. Traore M., Maitte M., Delerm B., Roy J.-C., Sequeira H. Opioid peptide involvement in the bulbar inhibition of electrodermal activity in the cat. J Physiol Paris. 92:1998;17-23.
397. Tsuchida A., Miura T., Tanno M., Nozawa Y., Kita H., Kazuaki S. Time window for the contribution of the δ-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc Drug Ther. 12:1998;365-373.
398. Tsueda K., Mosca P.J., Heine M.F., Loyd G.E., Durkis D.A.E., Malkani A.L., Hurst H.E. Mood during epidural patient-controlled analgesia with morphine or fentanyl. Anesthesiology. 88:1998;885-891.
399. Turchan J., Przewlocka B., Lason W., Przewlocki R. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience. 85:1998;1051-1059.
400. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm a comprehensive review of drug effects, recent progress and new issues . Prog Neurobiol. 56:1998;613-672.
401. Ukai M., Mori E., Kameyama T. Effects of intracerebroventricular injection of opioid peptides selective for μ, δ and κ receptors on discriminative stimulus properties of pentazocine in the rat. Hum Psychopharmacol Clin Exp. 13:1998;171-176.
402. Van Bockstaele E.J. Morphological substrates underlying opioid, epinephrine and γ-aminobutyric acid inhibitory actions in the rat locus coeruleus. Brain Res Bull. 47:1998;1-15.
403. Van Leeuwen A.F., Blake D.W., Ludbrook J. Correction of hypovolemic hypotension by centrally administered naloxone in conscious rabbits. Amer J Physiol Heart Circ Phy. 43:1998;H1371-H1377.
404. Vathy I., Valiskova J., Moshe S.L. Prenatal morphine exposure induces age-related changes in seizure susceptibility in male rats. Pharm Biochem Behav. 60:1998;635-638.
405. 9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central μ opioid receptors in adult offspring female rats. Brain Res. 807:1998;101-109.
406. Venteicher A., Armstead W.M. Vasopressin contributes to dynorphin modulation of hypoxic cerebrovasodilation. Amer J Physiol Heart Circ Phy. 44:1998;H2072-H2079.
407. Verborgh C., De Coster R., D'Haese J., Camu F., Meert T.F. Effects of chlordiazepoxide on opioid-induced antinociception and respiratory depression in restrained rats. Pharm Biochem Behav. 59:1998;663-670.
408. Vidal E.L., Patel N.A., Wu G., Fiala M., Chang S.L. IL-1 induces the expression of μ opioid receptors in endothelial cells. Immunopharmacology. 38:1998;261-266.
409. Vivian J.A., Kishioka S., Butelman E.R., Broadbear J., Lee K.O., Woods J.H. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys antagonist effects of SR 141716A . J Pharmacol Exp Ther. 286:1998;697-703.
410. Vivian J.A., Miczek K.A. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats. Psychopharmacology (Berl). 139:1998;364-375.
411. Von Horsten S., Nave H., Ballof J., Helfritz F., Meyer D., Schmidt R.E., Stalp M., Exton N.G., Exton M.S., Straub R.H., Radulovic J., Pabst R. Centrally applied NPY mimics immunoactivation induced by nonanalgesic doses of met-enkephalin. NeuroReport. 9:1998;3881-3885.
412. Vuckovic S., Ivanovic M., Prostran M., Todorovic Z., Ristovic Z., Micovic I., Beleslin D. Higher environmental temperature potentiates cataleptic effect of fentanyl in rats. Jpn J Pharmacol. 78:1998;523-527.
413. Waddell A.B., Holtzman S.G. Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists. Behav Pharmacol. 9:1998;397-407.
414. Walker D.J., Zacny J.P. Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology. 140:1998;191-201.
415. Wand G.S., Mangold D., Deiry S.E., McCaul M.E., Hoover D. Family history of alcoholism and hypothalamic opioidergic activity. Arch Gen Psychiatry. 55:1998;1114-1119.
416. Wang J.J., Ho S.T., Tzeng J.I. Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects. Reg Anesth Pain Med. 23:1998;479-484.
417. Wang T.-L., Chang H., Hung C.-R., Tseng Y-Z. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc Res. 40:1998;557-563.
418. Watson W.A., Steele M.T., Muelleman R.L., Rush M.D. Opioid toxicity recurrence after an initial response to naloxone. Clin Toxicol. 36:1998;11-17.
419. Weil J., Eschenhagen T., Fleige G., Mittmann C., Orthey E., Scholz H. Localization of preproenkephalin mRNA in rat heart selective gene expression in left ventricular myocardium . Amer J Physiol Heart Circ Phy. 275:(44):1998;H378-H384.
420. Weinger M.B., Chaplan S.R., Girten B.E., Powell F.L. The respiratory effects of the cytokine regulating agent HP 228 aline and in combination with morphine in human volunteers. Pharm Biochem Behav. 59:1998;759-766.
421. Weinstein A., Feldtkeller B., Malizia A., Wilson S., Bailey J., Nutt D.J. Integrating the cognitive and physiological aspects of craving. J Psychopharmacol. 12:1998;31-38.
422. Wenzlaff H., Stein B., Teschenmacher H. Diminution of contractile response by κ-opioid receptor agonists in isolated rat ventricular cardiomyocytesis mediated via a pertussis toxin-sensitive G protein. Naunyn-Schmiedberg's Arch Pharmacol. 358:1998;360-366.
423. Wewers M.E., Dhatt R., Tejwani G.A. Naltrexone administration affects ad lib smoking behavior. Psychopharmacology. 140:1998;185-190.
424. Wikström L.-M., Rökaeus Å., Fried G. Effects of acute stress on the contents of catecholamines and neuropeptides in chromaffin tissues of the newborn rabbit. Reg Pept. 78:1998;125-131.
425. Williams K.L., Winger G., Pakarinen E.D., Woods J.H. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology. 139:1998;53-61.
426. Williams K.L., Woods J.H. Oral ethanol-reinforced responding in rhesus monkeys effects of opioid antagonists selective for the μ-, κ-, or δ-receptor . Alcohol Clin Exp Res. 22:1998;1634-1639.
427. Williams P.I., Sarginson R.E., Ratcliffe J.M. Use of methadone in the morphine-tolerant burned pediatric patient. Br J Anaesth. 80:1998;92-95.
428. Woldbye D.P.D., Klemp K., Madsen T.M. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. J Pharmacol Exp Ther. 284:1998;633-636.
429. Won J.-S., Im Y.-B., Kim Y.-H., Song D.-K., Huh S.-O., Suh H-W. The modulatory role of nitric oxide in the regulation of proenkephalin and prodynorphin gene expressions induced by kainic acid in rat hippocampus. Mol Brain Res. 56:1998;76-83.
430. Wongchanapai W., Tsang B.K., He Z., Ho I.K. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine. Pharm Biochem Behav. 60:1998;899-907.
431. Wongchanapai W., Tsang B.K., He Z., Ma T., Ho I.K. Supersensitivity of spinal opioid receptors to antagonists in intrathecal butorphanol and morphine dependence. Life Sci. 63:1998;2175-2180.
432. Wright A.W., Nocente M.L., Smith M.T. Hydromorphine-3-glucuronide biochemical synthesis and preliminary pharmacological evaluation . Life Sci. 63:1998;401-411.
433. 5]-enkephalin, preproenkephalin gene expression, and the ζ opioid receptor in the developing and adult aorta of rat. Dev Dynam. 211:1998;327-337.
434. Xu J.Y., Hill K.P., Bidlack J.M. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J Pharmacol Exp Ther. 284:1998;196-201.
435. Yakimova K.S., Sann H., Pierau F-K. Effects of kappa and delta opioid agonists on activity and thermosensitivity of rat hypothalamic neurons. Brain Res. 786:1998;133-142.
436. Yamaguchi T., Kitagawa K., Kuraishi Y. Itch-associated response and antinociception induced by intracisternal endomorphins in mice. Jpn J Pharmacol. 78:1998;337-343.
437. Yokotani K., Osumi Y. Involvement of mu-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach. Jpn J Pharmacol. 78:1998;93-95.
438. 2+ stroes in NG108-15 cells. Brain Res. 802:1998;9-18.
439. Yuan C.-S., Foss J.F., O'Connor M., Moss J., Roizen M.F. Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol. 38:1998;931-935.
440. Yuan C.-S., Foss J.F., O'Connor M., Roizen M.F., Moss J. Effects of low-dose morphine on gastric emptying in healthy volunteers. J Clin Pharmacol. 38:1998;1017-1020.
441. Yurdaydin C., Karavelioglu D., Onaran O., Çelik T., Yasa M.H., Uzunalimoglu Ö. Opioid receptor ligands in human hepatic encephalopathy. J Hepatology. 29:1998;796-801.
442. 5-enkephalin administration . Brain Res Bull. 47:1998;237-248.
443. Zacny J.P., Hill J.L., Black M.L., Sadeghi P. Comparing the subjective, psychomotor, and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther. 286:1998;1197-1207.
444. Zhai Q.Z., Ingenito A.J. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats. J Cardiovasc Pharmacol. 31:1998;806-812.
445. Zhang L.C., Buccafusco J.J. Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms. Brain Res. 803:1998;114-121.
446. Zhang M., Gosnell B.A., Kelley A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther. 285:1998;908-914.
447. Zhao J., Zhang Y., Xin S.-M., Ma L., Pei G. Attenuation of nociceptin/orphanin FQ-induced signaling by N-methyl-D-aspartate in neuronal cells. Neuroreport. 9:1998;631-636.
448. Zhong F., Li X.-Y., Yang S.-L., Stefano G.B., Fimiani C., Bilfinger T.V. Methionine-enkephalin stimulates IL-6 mRNA expression human plasma levels in coronary artery bypass grafting . Int J Cardiol. 64:1998;S53-S59.
449. Zhu Y., Hsu M.-S., Pintar J.E. Developmental expression of the μ, κ, and δ opioid receptor mRNAs in mouse. J Neurosci. 18:1998;2538-2549.
450. Ziólkowska B., Przewlocka B., Mika J., Labuz D., Przewlocki R. Evidence for Fos involvement in the regulation of proenkephalin and prodynorphin gene expression in the rat hippocampus. Mol Brain Res. 54:1998;243-251.